NASDAQ: GPCR · Biotechnology
Over the past week, Structure Therapeutics (GPCR) pulled in 18 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 50% bullish but is deeply split: News runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 15 of 16 analysts rating GPCR a buy.
There is little buzz around GPCR this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 94% buy share sits next to a crowd that ranges from Reddit at 0% to News at 100%. No other tracker puts the two side by side.
Across 16 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $105.78.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 44 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Structure Therapeutics (GPCR) buzz held subdued around 26.2 while the price drifted down 24.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.3M shares. Updated Sep 26, 2026. Over the last 7 trading days, GPCR gained 2.4%. Buzz activity in the recent week averaged 34.2 and was relatively stable, swinging between 26.2 and 42.9. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 11 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GPCR and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GPCR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (15 / 1 / 0) |
| Crowd bullish (7d) | 50% |
| Avg price target | $105.78 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 18 |
| Market cap | $2.57B |
| EPS · Beta | -$3.03 · -1.5 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Structure Therapeutics (GPCR) currently carries an Adanos hold signal with 57/100 conviction. The current cross-source average reads 50% bullish across 3 active sources. Those sources contribute 18 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Structure Therapeutics (GPCR) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads split on Structure Therapeutics (GPCR), averaging 50% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 15 of 16 analysts rate GPCR a buy.
Of the 16 analysts covering Structure Therapeutics (GPCR), 15 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $105.78. That puts the street ahead of the crowd, which averages 50% bullish.
Structure Therapeutics (GPCR)'s cross-source average is mixed at 50% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. X reads 50% bullish, News reads 100% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 57/100 conviction.
The cross-source average is mixed for Structure Therapeutics (GPCR) at 50% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across X. The hold signal carries 57/100 conviction.
X is the dominant discussion channel with 16 mentions (89% of total volume). Reddit contributes 1 mention and News contributes 1 mention. The cross-source average is mixed at 50% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GPCR's hold signal at 57/100 conviction reflects a mixed cross-source average at 50% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The GPCR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key